Alveolar soft part sarcoma

source: shutterstock.com

Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research

Post author:Jessica Lynn
Post published:April 12, 2023
Post category:Alveolar soft part sarcoma Sarcoma Soft Tissue Sarcoma

Rare Community Profiles Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

source: shutterstock.com

ICYMI: FDA Approves Tecentriq for Alveolar Soft Part Sarcoma

Post author:Jessica Lynn
Post published:January 9, 2023
Post category:Alveolar soft part sarcoma

While alveolar soft part sarcoma (ASPS) is considered to be relatively slow-growing, it is necessary to carefully manage this rare soft tissue sarcoma to avoid metastasizing. Surgery is one…

The FDA Approves New Therapy for Rare Alveolar Soft Part Sarcoma (ASPS)

Post author:Rose Duesterwald
Post published:December 13, 2022
Post category:Alveolar soft part sarcoma

Genetech recently announced the FDA’s approval of Tecentriq to treat alveolar soft part sarcoma (ASPS) pediatric and adult patients over the age of two. This first-ever treatment has been developed…

Get Involved

Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research

ICYMI: FDA Approves Tecentriq for Alveolar Soft Part Sarcoma

The FDA Approves New Therapy for Rare Alveolar Soft Part Sarcoma (ASPS)

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Get Involved

Let’s Work Together!

Keep Up to Date

Learn More